Leerink Partners Maintains Outperform on Edwards Lifesciences, Raises Price Target to $112

Benzinga · 3d ago
Leerink Partners analyst Mike Kratky maintains Edwards Lifesciences (NYSE:EW) with a Outperform and raises the price target from $101 to $112.